1,7-phenanthroline has been researched along with Triple Negative Breast Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, N; Batista, AA; Costa-Filho, AJ; Ellena, J; Facchin, G; Fernández, CY; Leite, CM; Mendes, LFS; Napoleone, A; Ribeiro, RR | 1 |
| Das, R; Paira, P | 1 |
| Alvarez, N; Batista, AA; Costa-Filho, AJ; Ellena, J; Facchin, G; Leite, CM; Mendes, LFS; Viña, D | 1 |
| Bodman-Smith, K; Daher, CF; Khnayzer, RS; Mansour, N | 1 |
| Asano, Y; Kubota, S; Miyazaki, K; Nakajima, W; Tanaka, N | 1 |
| Deng, Y; Fan, L; Liao, Z; Liu, Y; Tian, M; Xu, J | 1 |
| Brabec, V; Kasparkova, J; Kostrhunova, H; Novohradsky, V; Pracharova, J; Štarha, P; Trávníček, Z | 1 |
7 other study(ies) available for 1,7-phenanthroline and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Tetramethyl-phenanthroline copper complexes in the development of drugs to treat cancer: synthesis, characterization and cytotoxicity studies of a series of copper(II)-L-dipeptide-3,4,7,8-tetramethyl-phenanthroline complexes.
Topics: Antineoplastic Agents; Cisplatin; Coordination Complexes; Copper; Dipeptides; DNA; Humans; MCF-7 Cells; Phenanthrolines; Triple Negative Breast Neoplasms | 2022 |
GSH resistant, luminescent 2-(pyren-1-yl)-1
Topics: Antineoplastic Agents; Coordination Complexes; DNA; Humans; Phenanthrolines; Ruthenium; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2023 |
Synthesis and structural characterization of a series of ternary copper(II)-L-dipeptide-neocuproine complexes. Study of their cytotoxicity against cancer cells including MDA-MB-231, triple negative breast cancer cells.
Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Chelating Agents; Coordination Complexes; Copper; Dipeptides; DNA; Humans; MCF-7 Cells; Phenanthrolines; Triple Negative Breast Neoplasms | 2020 |
A photoactivatable Ru (II) complex bearing 2,9-diphenyl-1,10-phenanthroline: A potent chemotherapeutic drug inducing apoptosis in triple negative human breast adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Phenanthrolines; Photochemical Processes; Ruthenium; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2021 |
Krüppel-Like Factor 4 and Its Activator APTO-253 Induce NOXA-Mediated, p53-Independent Apoptosis in Triple-Negative Breast Cancer Cells.
Topics: Apoptosis; Biomarkers, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Phenanthrolines; Prognosis; Proto-Oncogene Proteins c-bcl-2; Survival Rate; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2021 |
Salicylate •Phenanthroline copper (II) complex induces apoptosis in triple-negative breast cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Mice; Organometallic Compounds; Phenanthrolines; Salicylates; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2017 |
Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Osmium; Phenanthrolines; Ruthenium; Triple Negative Breast Neoplasms | 2018 |